Clinical Trials

A first-in-human study for the evaluation of the safety, pharmacokinetics and antitumor activity of SAR408701 in patients with advanced solid tumor


Study ID
Sanofi TED13751

NCT Number
NCT02187848 (Click on the NCT number for more information about the trial)

Research Study Number
2018-0400

Principle Investigator
Dr. Martin Gutierrez

Phase
I

Sponsor
Sanofi


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now